NCT00330486View on ClinicalTrials.gov

Open Label Trial of Acamprosate in Bipolar Alcoholics

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Alcohol DependenceBipolar Disorder
Interventions
DRUG

Acamprosate

Trial Locations (1)

29425

Institute of Psychiatry, Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT00330486 - Open Label Trial of Acamprosate in Bipolar Alcoholics | Biotech Hunter | Biotech Hunter